Evidence map›Paper›PMID 24474086›Full record

Trial reportJournal of thrombosis and thrombolysis2014

Elevated plasma CL-K1 level is associated with a risk of developing disseminated intravascular coagulation (DIC).

Kazue Takahashi, Katsuki Ohtani, Mykol Larvie, Patience Moyo, Lorencia Chigweshe, Elizabeth M Van Cott, Nobutaka Wakamiya

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of thrombosis and thrombolysis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 33 citations in OpenAlex.

  1. The Complement System.Advances in experimental medicine and biology · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Complement Recognition Pathways in Renal Transplantation.Journal of the American Society of Nephrology : JASN · 2017
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Changes in Mannose-Binding Lectin and Collectin Kidney 1 Levels in Sepsis Patients With and Without Disseminated Intravascular Coagulation.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Kazue TakahashiDepartment of Pediatrics, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA, ktakahashi1@gmail.com.
Katsuki Ohtani
Mykol Larvie
Patience Moyo
Lorencia Chigweshe
Elizabeth M Van Cott
Nobutaka Wakamiya
Harvard University · USAsahikawa Medical University · JPMassachusetts General Hospital · US

Funding

Development of novel immunotherapy for influenza virus infectionU01AI074503 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI TAKAHASHI, KAZUE · 2007 to 2011
$4.7M
NIAID NIH HHS U01 AI074503PHS HHS U01-074503
6 · The paper itself

Abstract

Collectin kidney 1 (CL-K1) is a recently identified collectin that is synthesized in most organs and circulates in blood. CL-K1 is an innate immune molecule that may play a significant role in host defense. As some collectins also play a role in coagulation, we hypothesized that an effect of CL-K1 may be apparent in disseminated intravascular coagulation (DIC), a gross derangement of the coagulation system that occurs in the setting of profound activation of the innate immune system. DIC is a grave medical condition with a high incidence of multiple organ failure and high mortality and yet there are no reliable biomarkers or risk factors. In our present study, we measured plasma CL-K1 concentration in a total of 659 specimens, including 549 DIC patients, 82 non-DIC patients and 27 healthy volunteers. The median plasma CL-K1 levels in these cohorts were 424, 238 and 245 ng/ml, respectively, with no significant difference in the latter two groups. The incidence of elevated plasma CL-K1 was significantly higher in the DIC patients compared to the non-DIC patients, resulting in an odds ratio of 1.929 (confidence interval 1.041-3.866). Infection, renal diseases, respiratory diseases, and cardiac diseases were more frequently observed in the DIC group than in the non-DIC group. In the DIC group, vascular diseases were associated with elevated plasma CL-K1 levels while age and acute illness had little effect on plasma CL-K1 levels. Independent of DIC, elevated plasma CL-K1 levels were associated with respiratory disease and coagulation disorders. These results suggest that specific diseases may affect CL-K1 synthesis in an organ dependent manner and that elevated plasma CL-K1 levels are associated with the presence of DIC. Further investigations in cohorts of patients are warranted. We propose that elevated plasma CL-K1 may be a new useful risk factor and possibly biomarker for the prediction of developing DIC.

Indexed as

AgedAge FactorsBiomarkersBlood Coagulation DisordersCohort StudiesCollectinsDisseminated Intravascular CoagulationHumansMaleMiddle AgedRespiratory Tract DiseasesRisk FactorsBiomarkersColec11 protein, humanCollectins

Identifiers

PMID24474086
PMCPMC6362979
OpenAlexW2078281513

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.